- Home
- PRPO vs SRTS Comparison
PRPO vs SRTS Comparison
Compare PRPO & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRPO | SRTS |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 45.6M |
| IPO Year | 2000 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PRPO | SRTS |
|---|---|---|
| Price | $19.02 | $2.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 34.2K | ★ 495.2K |
| Earning Date | 11-10-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $24,049,000.00 | ★ $27,482,000.00 |
| Revenue This Year | $233.72 | N/A |
| Revenue Next Year | $22.61 | $41.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $17.79 | $2.66 |
| 52 Week High | $33.63 | $5.49 |
Technical Indicators
Market Signals| Indicator | PRPO | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 39.94 | 66.09 |
| Support Level | $19.37 | $2.80 |
| Resistance Level | $24.78 | $3.71 |
| Average True Range (ATR) | 1.01 | 0.34 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 37.67 | 22.18 |
Price Performance
Historical ComparisonAbout PRPO Precipio Inc.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.